TRAVASOL 10% W/O ELECTROLYTES Drug Patent Profile
✉ Email this page to a colleague
When do Travasol 10% W/o Electrolytes patents expire, and when can generic versions of Travasol 10% W/o Electrolytes launch?
Travasol 10% W/o Electrolytes is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in TRAVASOL 10% W/O ELECTROLYTES is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Travasol 10% W/o Electrolytes
A generic version of TRAVASOL 10% W/O ELECTROLYTES was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for TRAVASOL 10% W/O ELECTROLYTES
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRAVASOL 10% W/O ELECTROLYTES at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRAVASOL 10% W/O ELECTROLYTES
US Patents and Regulatory Information for TRAVASOL 10% W/O ELECTROLYTES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | TRAVASOL 10% W/O ELECTROLYTES | amino acids | INJECTABLE;INJECTION | 017493-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |